Revenue
$10.23B
Fiscal year ended 2026-09-30Operating income
$3.02B
Fiscal year ended 2026-09-30Free cash flow
$1.62B
Fiscal year ended 2026-09-30Valuation, from the filing
| Public float | $106.03B | Market value of stock held by non-affiliates, as stated on the cover page for 2025-06-30 |
|---|---|---|
| Float per share | $86.26 | Float divided by shares outstanding in the same filing. A floor under the share price on that date, not the price itself. |
| Float / net income | 24.8× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / revenue | 4.6× | A lower bound on the multiple, because affiliate holdings are excluded. |
| Float / equity | 7.9× | A lower bound on the multiple, because affiliate holdings are excluded. |
Every figure here is drawn from the 10-K cover page and the statements behind it, so each one traces to a filing. Public float counts only stock held by non-affiliates, which makes these floors rather than estimates: a high multiple is conclusive, a low one may mean cheap or may mean closely held. The float was measured on 2025-06-30, not today, and each multiple below it uses the figures for the fiscal year ending 2025-12-31 — the year that filing covered.
Valuation over time
24.8× earnings today, against a median of 21.9× across 10 years on record. Above its own history.
| Float measured | Public float | Float / net income | |
|---|---|---|---|
| 2025-06-30 | $106.03B | 24.8× | |
| 2024-06-30 | $70.60B | 29.1× | |
| 2023-06-30 | $44.19B | 22.9× | |
| 2022-06-30 | $33.61B | 17.7× | |
| 2021-06-30 | $36.30B | 22.8× | |
| 2020-06-30 | $25.25B | 21.0× | |
| 2019-06-30 | $21.24B | 18.4× | |
| 2018-06-30 | $19.93B | 16.5× | |
| 2017-06-30 | $17.32B | 26.6× | |
| 2016-06-30 | $15.42B | 18.7× |
Each float is paired with the fiscal year the filing that stated it covers. Only years where the company reported positive net income appear, because a multiple against a loss is not a multiple.
AMPHENOL CORP /DE/ (APH) reported revenue of $10.23B and net income of $2.03B for the fiscal year ended 2026-09-30. This page shows 10 annual periods of income statement, balance sheet and cash flow figures normalized from AMPHENOL CORP /DE/’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Electronic Connectors.
Income
| Metric | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $10.23B | $8.76B | $7.62B | $6.44B | $6.19B | $5.65B | $4.81B | $4.32B | $4.04B | $3.61B |
| Cost of revenue | $6.21B | $5.21B | $4.82B | $3.98B | $3.84B | $3.60B | $3.17B | $2.84B | $2.68B | $2.40B |
| Gross profit | $4.02B | $3.55B | $2.80B | $2.46B | $2.36B | $2.05B | $1.64B | $1.48B | $1.36B | $1.21B |
| Operating income | $3.02B | $2.58B | $1.83B | $1.72B | $1.70B | $1.42B | $1.02B | $953.70M | $819.50M | $698.80M |
| Net income | $2.03B | $1.77B | $933.00M | $1.20B | $1.25B | $1.09B | $737.80M | $746.20M | $604.40M | $524.80M |
| Research & development | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Weighted-average diluted shares | shares 2.58B | shares 1.29B | shares 1.29B | Unavailable | shares 2.57B | shares 1.27B | shares 1.27B | Unavailable | shares 1.27B | shares 1.26B |
| Pretax income | $2.83B | $2.39B | $1.65B | $1.65B | $1.64B | $1.35B | $962.90M | $910.30M | $775.00M | $663.80M |
| Income tax expense | $774.50M | $604.30M | $702.40M | $443.60M | $385.80M | $247.30M | $218.70M | $158.30M | $166.10M | $135.10M |
| Diluted EPS | $0.79 | $1.37 | $0.72 | Unavailable | $0.49 | $0.86 | $0.58 | Unavailable | $0.48 | $0.41 |
| Selling, general & administrative | $979.90M | $939.90M | $851.50M | $691.00M | $657.00M | $622.50M | $575.20M | $515.00M | $492.00M | $444.30M |
| General & administrative | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Selling & marketing | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
Balance
| Metric | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $4.17B | $4.73B | $4.13B | $11.13B | $3.80B | $3.21B | $1.66B | $3.32B | $1.56B | $1.25B |
| Total assets | $47.02B | $44.81B | $42.13B | $36.24B | $27.14B | $25.67B | $22.90B | $21.44B | $19.59B | $18.59B |
| Current assets | $19.48B | $17.82B | $15.38B | $20.27B | $12.38B | $11.30B | $9.13B | $9.69B | $7.77B | $6.97B |
| Total liabilities | $29.75B | $29.18B | $28.04B | $22.73B | $14.54B | $14.07B | $12.53B | $11.58B | $10.06B | $9.54B |
| Current liabilities | $10.04B | $9.44B | $8.97B | $6.80B | $5.98B | $5.60B | $4.59B | $4.08B | $3.90B | $3.46B |
| Total equity incl. NCI | $17.26B | $15.61B | $14.08B | $13.50B | $12.60B | $11.59B | $10.36B | $9.85B | $9.51B | $9.03B |
| Temporary (mezzanine) equity | $9.00M | $9.00M | $9.10M | $9.30M | $10.20M | $10.10M | $9.30M | $8.70M | $20.70M | $19.90M |
| Inventory | $5.26B | $4.55B | $4.09B | $3.42B | $3.30B | $3.14B | $2.91B | $2.55B | $2.58B | $2.40B |
| Accounts receivable | $7.78B | $6.79B | $5.87B | $4.72B | $4.54B | $4.27B | $3.92B | $3.29B | $3.13B | $2.86B |
| Goodwill | $17.70B | $17.55B | $17.54B | $10.58B | $9.87B | $9.65B | $9.27B | $8.24B | $8.35B | $8.26B |
| Long-term debt | $17.17B | $17.18B | $16.64B | $14.56B | $7.13B | $7.13B | $6.82B | $6.48B | $5.08B | $5.04B |
| Accounts payable | $4.87B | $4.01B | $3.18B | $2.66B | $2.46B | $2.37B | $2.14B | $1.82B | $1.76B | $1.52B |
Cash flow
| Metric | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $2.08B | $1.56B | $1.12B | $1.72B | $1.47B | $1.42B | $764.90M | $847.10M | $704.00M | $664.10M |
| Capital expenditures | $457.20M | $355.50M | $291.60M | $253.70M | $257.20M | $297.10M | $188.60M | $199.80M | $230.00M | $141.30M |
| Investing cash flow | -$1.28B | -$672.80M | -$11.03B | -$1.50B | -$614.40M | -$611.60M | -$2.35B | -$250.40M | -$202.50M | -$2.18B |
| Financing cash flow | -$1.39B | -$313.10M | $2.90B | $7.08B | -$266.30M | $700.90M | -$88.60M | $1.21B | -$227.60M | $919.60M |
| Net change in cash | -$556.30M | $601.40M | -$7.00B | $7.33B | $592.30M | $1.55B | -$1.66B | $1.75B | $310.50M | -$604.60M |
| Stock-based compensation | $47.00M | $45.40M | $34.20M | $40.60M | $36.90M | $31.30M | $26.60M | $29.60M | $29.50M | $26.60M |
| Common dividends paid | $308.00M | $307.40M | $306.70M | $201.90M | $201.20M | $199.60M | $199.50M | $198.90M | $132.40M | $132.10M |
| Common share repurchases | $244.60M | $208.00M | $178.00M | $171.30M | $152.90M | $160.10M | $180.90M | $168.90M | $176.20M | $190.40M |
| Depreciation & amortization | $347.80M | $341.40M | $485.80M | $249.00M | $227.70M | $209.40M | $236.30M | $143.80M | $201.20M | $123.60M |
Derived
| Metric | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|---|---|
| Free cash flow | $1.62B | $1.20B | $829.90M | $1.47B | $1.21B | $1.12B | $576.30M | $647.30M | $474.00M | $522.80M |
| Gross margin | 39.3% | 40.5% | 36.7% | 38.2% | 38.1% | 36.3% | 34.2% | 34.3% | 33.6% | 33.6% |
| Operating margin | 29.5% | 29.5% | 24.0% | 26.8% | 27.5% | 25.1% | 21.3% | 22.1% | 20.3% | 19.4% |
| FCF margin | 15.8% | 13.7% | 10.9% | 22.8% | 19.6% | 19.8% | 12.0% | 15.0% | 11.7% | 14.5% |
| SBC / revenue | 0.5% | 0.5% | 0.4% | 0.6% | 0.6% | 0.6% | 0.6% | 0.7% | 0.7% | 0.7% |
| Current ratio | 1.94x | 1.89x | 1.71x | 2.98x | 2.07x | 2.02x | 1.99x | 2.37x | 1.99x | 2.02x |
| Revenue YoY growth | 65.1% | 55.0% | 58.4% | 49.1% | 53.4% | 56.5% | 47.7% | 29.8% | 26.2% | 18.2% |
| Net margin | 19.9% | 20.2% | 12.2% | 18.6% | 20.1% | 19.3% | 15.3% | 17.3% | 15.0% | 14.5% |
| R&D / revenue | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| CapEx / revenue | 4.5% | 4.1% | 3.8% | 3.9% | 4.2% | 5.3% | 3.9% | 4.6% | 5.7% | 3.9% |
| Long-term debt / equity | 0.99x | Unavailable | Unavailable | 1.08x | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable | Unavailable |
| Effective tax rate | 27.4% | 25.3% | 42.7% | 26.9% | 23.5% | 18.3% | 22.7% | 17.4% | 21.4% | 20.4% |
Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open APH in the interactive workspace to inspect any figure back to its filing.
Source filings
10-Q · Filed 2026-10-30View SEC filing
10-Q · Filed 2026-07-31View SEC filing
10-Q · Filed 2026-05-01View SEC filing
10-K · Filed 2026-02-11View SEC filing
10-Q · Filed 2025-10-24View SEC filing
10-Q · Filed 2025-07-25View SEC filing
Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.